Immuno-oncology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
3
NCT05192174
Study of NIB101 in Participants With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 24, 2022
Completion: May 16, 2025
Loading map...